{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T13:21:43Z","timestamp":1702300903482},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Malaria in pregnancy is a major health problem that can cause maternal anaemia, stillbirth, spontaneous abortion, low birth weight and intra-uterine stunting. The WHO recommends use of sulphadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria during pregnancy (IPTp) in endemic areas. Towards monitoring and assessing IPTp coverage in the population, the Roll Back Malaria Partnership recommends the use of self-reported data. The aim of this study was to assess the validity of self-reported IPTp by testing for sulphadoxine in maternal blood at delivery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Two hundred and four pregnant women were consented and enrolled in a cross-sectional study in Mulago National Referral Hospital in Kampala Uganda. - Participants who reported a history of taking sulpha-containing drugs like co-trimoxazole , those who were not sure of dates relating to last menstrual period or who took IPTp within the first 20\u2009weeks of gestation were excluded from the study. Data on demographic characteristics, obstetric history, and delivery outcome were collected. At birth, maternal venous blood was taken off aseptically and used to make thick blood smears for malaria parasites and plasma for determining sulphadoxine using high performance liquid chromatography (HPLC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 120 participants who self reported to have used IPTp, 35 (29.2%) tested positive for sulphadoxine by HPLC, while 63 (75%) of 84 patients who reported not having used IPTp tested negative for sulphadoxine. Participants possessing post-primary education were more likely to have reported using IPTp. The low agreement (kappa coefficient\u2009=\u20090.037) between self-report and actual presence of the drug in the blood casts doubt on the validity of self-reported data in estimating IPTp coverage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The results of this study question the accuracy of self-reported data in estimating IPTp coverage in the population. More studies on validity of self reported data are recommended. Since the validity of IPTp self reports is vital for guiding policy on malaria control in pregnancy, ways should be sought to improve accuracy of the information from such reports.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2875-11-310","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T12:14:20Z","timestamp":1346847260000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study"],"prefix":"10.1186","volume":"11","author":[{"given":"Fatuma","family":"Namusoke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ntale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Wahlgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Kironde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Mirembe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,5]]},"reference":[{"key":"2183_CR1","first-page":"186","volume":"2","author":"J Schantz-Dunn","year":"2009","unstructured":"Schantz-Dunn J, Nour NM: Malaria and pregnancy: a global health perspective. Rev Obstet Gynecol. 2009, 2: 186-192.","journal-title":"Rev Obstet Gynecol"},{"key":"2183_CR2","doi-asserted-by":"publisher","first-page":"e1000290","DOI":"10.1371\/journal.pmed.1000290","volume":"7","author":"SI Hay","year":"2010","unstructured":"Hay SI, Okiro EA, Gething PW, Patil AP, Tatem AJ, Guerra CA, Snow RW: Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med. 2010, 7: e1000290-10.1371\/journal.pmed.1000290.","journal-title":"PLoS Med"},{"key":"2183_CR3","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1046\/j.1365-3156.2001.00786.x","volume":"6","author":"CE Shulman","year":"2001","unstructured":"Shulman CE, Marshall T, Dorman EK, Bulmer JN, Cutts F, Peshu N, Marsh K: Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health. 2001, 6: 770-778. 10.1046\/j.1365-3156.2001.00786.x.","journal-title":"Trop Med Int Health"},{"key":"2183_CR4","volume-title":"WHO A strategic framework for malaria prevention and control during pregnancy in the African region","author":"World Health Organization\/AFR\/MAL","year":"2004","unstructured":"World Health Organization\/AFR\/MAL: WHO A strategic framework for malaria prevention and control during pregnancy in the African region. 2004, WHO, Geneva"},{"key":"2183_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0035-9203(00)90083-X","volume":"94","author":"SJ Rogerson","year":"2000","unstructured":"Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molyneux ME: Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997\u201399. Trans R Soc Trop Med Hyg. 2000, 94: 549-553. 10.1016\/S0035-9203(00)90083-X.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2183_CR6","volume-title":"Uganda Demographic Health Survey","author":"Uganda Bureau of Statistics Kampala, Uganda","year":"2011","unstructured":"Uganda Bureau of Statistics Kampala, Uganda: Uganda Demographic Health Survey. 2011, Measure DHS, ICF International, Calverton, Maryland, USA"},{"key":"2183_CR7","first-page":"913857","volume":"2010","author":"F Namusoke","year":"2010","unstructured":"Namusoke F, Rasti N, Kironde F, Wahlgren M, Mirembe F: Malaria burden in pregnancy at mulago national referral hospital in Kampala, Uganda. Malar Res Treat. 2010, 2010: 913857-","journal-title":"Malar Res Treat"},{"key":"2183_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.actatropica.2005.06.003","volume":"95","author":"H Sendagire","year":"2005","unstructured":"Sendagire H, Kaddumukasa M, Ndagire D, Aguttu C, Nassejje M, Pettersson M, Swedberg G, Kironde F: Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative. Acta Trop. 2005, 95: 172-182. 10.1016\/j.actatropica.2005.06.003.","journal-title":"Acta Trop"},{"key":"2183_CR9","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1001\/jama.297.23.2603","volume":"297","author":"FO terKuile","year":"2007","unstructured":"terKuile FO, vanEijk AM, Filler SJ: Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007, 297: 2603-2616. 10.1001\/jama.297.23.2603.","journal-title":"JAMA"},{"key":"2183_CR10","volume-title":"Guidelines for Core Population Coverage Indicators for Roll Back Malaria: To Be Obtained from Household Surveys","author":"Roll Back Malaria MEASURE Evaluation World Health Organization UNICEF","year":"2004","unstructured":"Roll Back Malaria MEASURE Evaluation World Health Organization UNICEF: Guidelines for Core Population Coverage Indicators for Roll Back Malaria: To Be Obtained from Household Surveys. 2004, MEASURE Evaluation, Calverton, Maryland, USA"},{"key":"2183_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trstmh.2008.04.046","volume":"103","author":"H Hildenwall","year":"2009","unstructured":"Hildenwall H, Lindkvist J, Tumwine JK, Bergqvist Y, Pariyo G, Tomson G, Peterson S: Low validity of caretakers' reports on use of selected antimalarials and antibiotics in children with severe pneumonia at an urban hospital in Uganda. Trans R Soc Trop Med Hyg. 2009, 103: 95-101. 10.1016\/j.trstmh.2008.04.046.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2183_CR12","doi-asserted-by":"publisher","first-page":"e8184","DOI":"10.1371\/journal.pone.0008184","volume":"4","author":"EM Hodel","year":"2009","unstructured":"Hodel EM, Kabanywanyi AM, Malila A, Zanolari B, Mercier T, Beck HP, Buclin T, Olliaro P, Decosterd LA, Genton B: Residual antimalarials in malaria patients from Tanzania\u2013implications on drug efficacy assessment and spread of parasite resistance. PLoS One. 2009, 4: e8184-10.1371\/journal.pone.0008184.","journal-title":"PLoS One"},{"key":"2183_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.annepidem.2010.03.017","volume":"20","author":"T Oksanen","year":"2010","unstructured":"Oksanen T, Kivimaki M, Pentti J, Virtanen M, Klaukka T, Vahtera J: Self-report as an indicator of incident disease. Ann Epidemiol. 2010, 20: 547-554. 10.1016\/j.annepidem.2010.03.017.","journal-title":"Ann Epidemiol"},{"key":"2183_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00007691-198706000-00013","volume":"9","author":"Y Bergqvist","year":"1987","unstructured":"Bergqvist Y, Hjelm E, Rombo L: Sulfadoxine assay using capillary blood samples dried on filter paper\u2013suitable for monitoring of blood concentrations in the field. Ther Drug Monit. 1987, 9: 203-207. 10.1097\/00007691-198706000-00013.","journal-title":"Ther Drug Monit"},{"key":"2183_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/clpt.2009.177","volume":"87","author":"MM Nyunt","year":"2010","unstructured":"Nyunt MM, Adam I, Kayentao K, van Dijk J, Thuma P, Mauff K, Little F, Cassam Y, Guirou E, Traore B, Doumbo O, Sullivan D, Smith P, Barnes KI: Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther. 2010, 87: 226-234. 10.1038\/clpt.2009.177.","journal-title":"Clin Pharmacol Ther"},{"key":"2183_CR16","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1086\/522632","volume":"196","author":"MD Green","year":"2007","unstructured":"Green MD, van Eijk AM, van Ter Kuile FO, Ayisi JG, Parise ME, Kager PA, Nahlen BL, Steketee R, Nettey H: Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. J Infect Dis. 2007, 196: 1403-1408. 10.1086\/522632.","journal-title":"J Infect Dis"},{"key":"2183_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics. 1977, 33: 159-174. 10.2307\/2529310.","journal-title":"Biometrics"},{"key":"2183_CR18","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera AJ, Garrett JM: Understanding interobserver agreement: the kappa statistic. Fam Med. 2005, 37: 360-363.","journal-title":"Fam Med"},{"key":"2183_CR19","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jclinepi.2004.04.005","volume":"57","author":"Y Okura","year":"2004","unstructured":"Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ: Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004, 57: 1096-1103. 10.1016\/j.jclinepi.2004.04.005.","journal-title":"J Clin Epidemiol"},{"key":"2183_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00007435-199905000-00006","volume":"26","author":"LH Bachmann","year":"1999","unstructured":"Bachmann LH, Stephens J, Richey CM, Hook EW: Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. Sex Transm Dis. 1999, 26: 272-278. 10.1097\/00007435-199905000-00006.","journal-title":"Sex Transm Dis"},{"key":"2183_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1023\/A:1018682530519","volume":"27","author":"LS Weinhardt","year":"1998","unstructured":"Weinhardt LS, Forsyth AD, Carey MP, Jaworski BC, Durant LE: Reliability and validity of self-report measures of HIV-related sexual behavior: progress since 1990 and recommendations for research and practice. Arch Sex Behav. 1998, 27: 155-180. 10.1023\/A:1018682530519.","journal-title":"Arch Sex Behav"},{"key":"2183_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1054-139X(03)00052-1","volume":"33","author":"ND Brener","year":"2003","unstructured":"Brener ND, Billy JO, Grady WR: Assessment of factors affecting the validity of self-reported health-risk behavior among adolescents: evidence from the scientific literature. J Adolescent Health. 2003, 33: 436-457. 10.1016\/S1054-139X(03)00052-1.","journal-title":"J Adolescent Health"},{"key":"2183_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1475-2875-7-79","volume":"7","author":"K Anders","year":"2008","unstructured":"Anders K, Marchant T, Chambo P, Mapunda P, Reyburn H: Timing of intermittent preventive treatment for malaria during pregnancy and the implications of current policy on early uptake in north-east Tanzania. Malar J. 2008, 7: 79-10.1186\/1475-2875-7-79.","journal-title":"Malar J"},{"key":"2183_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s10995-010-0608-5","volume":"15","author":"WA Oyibo","year":"2011","unstructured":"Oyibo WA, Agomo CO: Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges. Matern Child Health J. 2011, 15: 542-552. 10.1007\/s10995-010-0608-5.","journal-title":"Matern Child Health J"},{"key":"2183_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1475-2875-7-133","volume":"7","author":"AM Kabanywanyi","year":"2008","unstructured":"Kabanywanyi AM, Macarthur JR, Stolk WA, Habbema JD, Mshinda H, Bloland PB, Abdulla S, Kachur SP: Malaria in pregnant women in an area with sustained high coverage of insecticide-treated bed nets. Malar J. 2008, 7: 133-10.1186\/1475-2875-7-133.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-11-310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:43:28Z","timestamp":1630525408000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-11-310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2183"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-11-310","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,5]]},"assertion":[{"value":"7 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"310"}}